ArticleFrontiers in medicine2025
Association between metabolic dysfunction-associated fatty liver disease and risk of incidence of gallstones, evidence from a 5-year railway safety staff retrospective cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current evidence from cohort studies on the association between metabolic dysfunction-associated fatty liver disease (MAFLD) and gallstone formation remains limited. This 5-year retrospective cohort study aimed to evaluate the impact of MAFLD on gallstone incidence among railway safety staff. Methods: Data were obtained from the physical examination data of railway safety staff at Wuchang Hospital, Wuhan City, Hubei Province, China. The diagnosis of MAFLD was consistent with the international expert consensus. Independent associations between MAFLD and participants' risk of gallstone incidence were assessed by multiple Cox regression. Stratified analyses and interaction tests were performed to investigate whether covariates modified the association between MAFLD and gallstone incidence. Results: Among 1,422 participants, the risk of gallstone incidence was 9.27% (37/399) higher in the exposed group with MAFLD than in the control group 5.67% (58/1,023). Multiple cox regression showed that people with MAFLD were associated with a risk of gallstone incidence (HR = 1.71, 95% CI = 1.13-2.58). Stratified analysis by sex showed that men with MAFLD had a significantly increased risk (HR = 1.54, 95% CI: 1.00-2.38, Conclusions: There is a significant association between MAFLD and the incidence of gallstones. Attention should be paid to the prevention and treatment of MAFLD to promote the health of railway safety staff and reduce the burden ofanalysis gallstone-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.